ANI Pharmaceuticals, Inc. (ANIP): $33.91

1.03 (+3.13%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ANIP to Watchlist
Sign Up

Industry: Biotech


Ranked

of 487

in industry

Ani Pharmaceuticals Inc (ANIP) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ANIP.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
3 $45 $30 $38.33 $34.24 11.95%

ANIP reports an average of 38.1% for its upside potential over the past 28 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-11-18 3 45 30 38.33 28.15 36.16%
2020-10-21 3 45 30 38.33 27.29 40.45%
2020-08-07 3 45 30 38.33 30.37 26.21%
2020-08-06 3 48 30 39.33 29.50 33.32%
2020-07-21 3 49 40 45.67 29.59 54.34%
2020-05-07 3 49 40 45.67 NA NA%

ANIP Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 1 1 1 0 0 3

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • ANIP has a higher upside potential (average analyst target price relative to current price) than 13.24% of Pharmaceutical Products stocks.
  • Ani Pharmaceuticals Inc's average analyst price target is greater than 78.07% of stocks in the small market cap category.
  • ANIP has a greater number of analysts covering the stock than 22.88% of Pharmaceutical Products stocks.
  • ANIP has a lower variance in analysts' estimates than 28.71% of stocks in the small market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Ani Pharmaceuticals Inc are DSGN, SUPN and PLXP.

Is ANIP a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8132 seconds.